Virginia Board of Medicine Practitioner Information

Home Icon Home

Search Icon Search

Disclaimer Icon Disclaimers

Links Icon Links

Glossary Icon Glossary

Help Icon Questions


Printer Friendly Version Printer Icon
 

Mazen Abdel Razzaq Mohammed Salem Alsinnawi, MD

LICENSE # 0101268505
 
Issue Date: 1/14/2020
Expiration Date: 6/30/2024
Status: Current Active


General InformationEducationCertifications & Practice AreaInsuranceHonors & AwardsAcademic Appointments & PublicationsProceedings, Actions & ConvictionsPaid Claims
Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.


Academic Appointments
Last Updated 5/15/2022
University Of Pittsburgh School Of Medicine - Pittsburgh PA
Rank: Clinical Assistant Professor
Years: 2017-current

Academic Appointments - Non-US
Last Updated 5/15/2022
None Reported
Publications
(up to ten in the last five years)
Last Updated 5/15/2022
Transurethral resection of the prostate--"now and then".
Ir Med J.
108(5):144-6
Date: 05 2015

A 30-year experience of Millin's retropubic prostatectomy: Has this classic operation derived by a President of the College in Ireland stood the test of time?
Ir J Med Sci.
184(2):341-4.
Date: 06 2015

Delayed contrast-enhanced MRI to localize Botox after cystoscopic intravesical injection.
Int Urol Nephrol.
47(6):893-8
Date: 06 2015

Risk Factors and Significance of Gentamicin Resistant Positive Urine Culture in Patients Undergoing Urological Surgery: A Short Report.
Curr Urol.
8(4):175-177
Date: 12 2015

Does a Clear Understanding of Life Expectancy Increase Decisional Conflict and Anxiety for Men with Newly Diagnosed Prostate Cancer?
The Journal of Urology
195 (4), e31
Date: 01 2016

Ablative Therapies for Early Stage Kidney Cancer and the Evolving Role of the Urologist
Urology Pratice
Vol. 4, Issue 2, p168
Date: 11 2016

THE IMPACT OF PATHOLOGICAL RISK FACTORS AND THE MANAGEMENT OF STAGE I NON SEMINOMATOUS GERM CELL TESTICULAR CANCER.
The Journal of Urology
Vol. 197, Issue 4, e1015–e1016
Date: 04 2017

A prospective study of health-related quality of life outcomes among men treated for intermediate- and high-risk prostate cancer: the impact of primary and secondary therapies
Canadian Journal of urology
26(4):9809-9820
Date: 08 2019

Association of prostate cancer SLCO gene expression with Gleason grade and alterations following androgen deprivation therapy.
Prostate Cancer Prostatic Disease
22(4):560-568
Date: 12 2019